Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.73
-0.52 (-5.07%)
At close: Oct 31, 2025, 4:00 PM EDT
9.80
+0.07 (0.71%)
After-hours: Oct 31, 2025, 7:58 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $759.48 million as of October 31, 2025. Its market cap has increased by 5.47% in one year.
Market Cap
759.48M
Enterprise Value
432.47M
1-Year Change
5.47%
Ranking
Category
Stock Price
$9.73
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $759.48M, an increase of 62.45%. That is a compound annual growth rate of 6.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 800.07M | -14.15% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |